Commonly overlooked in a world where modern diseases remain at the forefront, tuberculosis (TB) claims four lives every minute. With its reemergence in the past few decades, it is now considered a pandemic emergency.The fight against TB is among MSH’s highest priorities. As a member of USAID’s Tuberculosis Control Assistance Program (TB CAP), the STOP TB Partnership, and the Global Fund, MSH works worldwide to ensure access to early case finding, diagnosis, and treatment. We provide technical leadership, training, and tools.

Although malaria is preventable and treatable, the World Health Organization reports that malaria affects between 300 and 500 million people per year. And malaria still claims the lives of more than 1 million children every year. Malaria’s impact on health systems and fragile economies is devastating to developing countries and their people. The fight against the disease is plagued by financial limitations, lack of community awareness, and drug-resistant malaria strains.

The Government of Angola declared an artemisinin-containing combination treatment (ACT), Coartem®, as its first-line malaria treatment because of the high levels of resistance to traditional antimalarial monotherapies, but it faced several challenges in getting the new medicines into its health facilities.